BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12825928)

  • 1. Simplified discodermolide analogues: synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents.
    Choy N; Shin Y; Nguyen PQ; Curran DP; Balachandran R; Madiraju C; Day BW
    J Med Chem; 2003 Jul; 46(14):2846-64. PubMed ID: 12825928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
    Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
    Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic analogues of the microtubule-stabilizing agent (+)-discodermolide: preparation and biological activity.
    Gunasekera SP; Mickel SJ; Daeffler R; Niederer D; Wright AE; Linley P; Pitts T
    J Nat Prod; 2004 May; 67(5):749-56. PubMed ID: 15165132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthetic analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity.
    Gunasekera SP; Longley RE; Isbrucker RA
    J Nat Prod; 2002 Dec; 65(12):1830-7. PubMed ID: 12502323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
    Harried SS; Lee CP; Yang G; Lee TI; Myles DC
    J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide.
    Smith AB; Freeze BS; Lamarche MJ; Hirose T; Brouard I; Rucker PV; Xian M; Sundermann KF; Shaw SJ; Burlingame MA; Horwitz SB; Myles DC
    Org Lett; 2005 Jan; 7(2):311-4. PubMed ID: 15646985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
    ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
    Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of simplified analogues of (+)-discodermolide. Additional insights on the importance of the diene, the C7 hydroxyl, and the lactone.
    Smith AB; Xian M
    Org Lett; 2005 Nov; 7(23):5229-32. PubMed ID: 16268545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, total synthesis, and evaluation of C13-C14 cyclopropane analogues of (+)-discodermolide.
    Smith AB; Xian M; Liu F
    Org Lett; 2005 Oct; 7(21):4613-6. PubMed ID: 16209492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
    Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
    Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
    Paterson I; Gardner NM; Guzmán E; Wright AE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
    Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
    ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discodermolide/Dictyostatin hybrids: synthesis and biological evaluation.
    Shin Y; Choy N; Turner TR; Balachandran R; Madiraju C; Day BW; Curran DP
    Org Lett; 2002 Dec; 4(25):4443-6. PubMed ID: 12465908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide.
    Mínguez JM; Kim SY; Giuliano KA; Balachandran R; Madiraju C; Day BW; Curran DP
    Bioorg Med Chem; 2003 Jul; 11(15):3335-57. PubMed ID: 12837544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
    Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies.
    Martello LA; LaMarche MJ; He L; Beauchamp TJ; Smith AB; Horwitz SB
    Chem Biol; 2001 Sep; 8(9):843-55. PubMed ID: 11564553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and high content cell-based profiling of simplified analogues of the microtubule stabilizer (+)-discodermolide.
    Minguez JM; Giuliano KA; Balachandran R; Madiraju C; Curran DP; Day BW
    Mol Cancer Ther; 2002 Dec; 1(14):1305-13. PubMed ID: 12516963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discodermolide analogues as the chemical component of combination bacteriolytic therapy.
    Smith AB; Freeze BS; LaMarche MJ; Sager J; Kinzler KW; Vogelstein B
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3623-6. PubMed ID: 15979874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.